Corbus Pharmaceuticals Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Corbus Pharmaceuticals Holdings, Inc. (CRBP) on September 15, 2020, reporting an event that occurred on September 11, 2020. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On September 11, 2020, David Hochman submitted his resignation from the Board of Directors, effective immediately. Consequently, Mr. Hochman also relinquished his positions on the Board's Finance Committee and Nominating and Corporate Governance Committee. The company stated that the resignation was not the result of any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific event of the director's departure.
Key Facts for Investor Verification
- David Hochman resigned from the Board of Directors and all committee assignments effective September 11, 2020.
- The resignation was not caused by any disagreement with the company.
- The company has not announced a replacement director in this filing.
- No financial data or operational updates are included in this specific report.